ADHD Alcobra Ltd.

1.14
0  -6%
Previous Close 1.21
Open 1.19
Price To book 0.71
Market Cap 31.42M
Shares 27,562,000
Volume 262,178
Short Ratio 1.64
Av. Daily Volume 732,300

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released January 17, 2017 - failed to meet primary endpoint.
MDX (Metadoxine Extended Release (MG01CI))
Adult ADHD
Phase 2b data released March 2015. Secondary cognitive measures did not produce statistically significant results.
MDX (Metadoxine Extended Release (MG01CI))
Pediatric ADHD
Phase 2 trial did not meet endpoints - June 2015.
MDX (Metadoxine Extended Release (MG01CI))
Fragile X Syndrome

Latest News

  1. Exodus Capital is Summoning an Extraordinary General Meeting
  2. Tenax Therapeutics and Alcobra Find Rough Waters Ahead
  3. Alcobra Provides Update on Request for Extraordinary General Meeting
  4. SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Alcobra Ltd.
  5. DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact The Firm
  6. IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  7. Brosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman
  8. IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  9. SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
  10. IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  11. SHAREHOLDER ALERT: SFMS Announces Filing of Securities Class Action Lawsuit Against Alcobra, Ltd.
  12. Alcobra Ltd. to Participate in Upcoming Healthcare Conferences
  13. INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm
  14. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
  15. Alcobra to Host Investor Forum and Webcast on March 28 in New York City
  16. IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  17. IMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of Alcobra Ltd.
  18. SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm
  19. Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm
  20. IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm